Document is current
Any future updates will be listed below
-
Authors
Duvignaud, Alexandre http://orcid.org/0000-0001-7139-2687
Lhomme, Edouard
Pistone, Thierry
Onaisi, Racha
Sitta, Rémi
Journot, Valérie
Nguyen, Duc
Peiffer-Smadja, Nathan
Crémer, Antoine
Bouchet, Stéphane
Darnaud, Thomas
Poitrenaud, Delphine
Piroth, Lionel
Binquet, Christine
Michel, Jean-François
Lefèvre, Benjamin
Lebeaux, David
Lebel, Josselin
Dupouy, Julie
Roussillon, Caroline
Gimbert, Anne
Wittkop, Linda
Thiébaut, Rodolphe
Orne-Gliemann, Joanna
Joseph, Jean-Philippe
Richert, Laura
Anglaret, Xavier
Malvy, Denis
,
-
Funding
Funding for this research was provided by:
Université de Bordeaux (NA)
INSERM (NA)
Agence Nationale de la Recherche (NA)
Ministère de la Santé (NA)
EIT Health (NA)
- License Information
-
More Information
Article History
Received: 13 July 2020
Accepted: 15 July 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: The study was approved by the “Comité de Protection des Personnes Ile de France 1” ethics committee (reference CPPIDF1-2020-ND45 cat.1) on April 7<sup>th</sup> 2020, and by the French regulatory Agency, “ANSM” (reference MEDAECNAT-2020-03-00065) on April 10<sup>th</sup> 2020, as required by national regulations regarding the evaluation of experimental drugs in humans. Eligible individuals may only be included in the study after receiving full explanation, having received sufficient time to consider the trial, asking questions and receiving satisfying responses to all questions, and after providing written Ethics Committee-approved informed consent. Individuals who are not able to understand the study and to provide informed consent by themselves are not eligible to participate.
: Not applicable.
: The authors declare that they have no competing interests.
